Gerteis® roller compaction could be the key to your future pharma solid dosage success
Focus:
-
![Eylea]()
The dominance of Eylea is expected to persist in the foreseeable future
-
![IPF]()
Significant clinical unmet needs remain in idiopathic pulmonary fibrosis
-
![AstraZeneca Veeva Covid-19]()
AstraZeneca and Veeva: reducing disruption from the Covid-19 pandemic
-
![ibd]()
Will Zeposia change the treatment paradigm in IBD?
-
![Dr Fauci]()
“There’s going to be more than one winner in the vaccine field” Says US top infectious disease expert Dr Anthony Fauci
-
![chronic kidney disease]()
Chronic kidney disease patients likely to go undiagnosed due to Covid-19 pandemic
Most Read
- AstraZeneca and Veeva: reducing disruption from the Covid-19 pandemic
- Veeva R&D summit 2020: putting patients at the centre of clinical research
- Breakthrough in neurodegeneration: GV, Bill Gates and Foresight invest $45m in Cerevance
- Turning pharma green: an eco-wish list for the industry
- A resolution for the new decade: resolve the US opioid crisis
Company A-Z
Latest Content
Phase I Study Completion on Gimsilumab for ARDS in Covid-19
Altasciences has finalised a Phase I study for the development of gimsilumab, up-regulated in SARS CoV-2 in patients with or at risk of developing acute respiratory distress syndrome (ARDS).
Moving in Unison
Altasciences is a forward-thinking, mid-size, early phase contract research organisation with a unique company focus on supporting drug development from lead candidate selection to proof of concept.
HOF Awarded TOP Innovator for the Fifth Time
The TOP 100 were honoured for the 27th time, the most innovative medium-sized companies and HOF were again among the best.
DFE to Exhibit at Online Event DPI China on 10 July
DFE is pleased to announce it will be speaking next month at DPI China as part of a special online conference,
Brand New Company Page and Expansion of Board of Directors
Kugelmeiers, one of the eleven start-ups enter the second phase of Scale-up Coaching, has received a brand new digital outfit.
Injection Vials for Vaccines for Protection Against Covid-19
Covid-19 vaccines under development to protect from the disease are, like numerous other drugs, filled in injection or vials comprised of type 1 borosilicate glass.
Webinar: Creating a Lean Culture in Pharma
CPL is pleased to announce it will be presenting its Creating a Lean Culture in Pharma webinar on 18 August at 2pm London / 3pm CET time.
Bioequivalence Studies and Bioanalytical Services
Anapharm Bioanalytics is a client-orientated, GLP-certified, FDA-inspected, GCP-compliant and ANVISA-certified bioanalytical contract research organisation (CRO) offering comprehensive high-quality bioanalytical services to the pharmaceutical, biotechnological and generic industry worldwide.
Latest News
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Close
Close
Close
Go Top